Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer

Journal of Urology

Volumn 181, Issue 4, 2009, Pages 1628-1634

  Conti, Simon L ^a   Dall'Era, Marc ^a   Fradet, Vincent ^a   Cowan, Janet E ^a   Simko, Jeffery ^a   Carroll, Peter R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

neoplasm staging; pathology; patient selection; prostatic neoplasms

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURGERY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SEMINAL VESICLE; TUMOR BIOPSY;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POPULATION SURVEILLANCE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 62049083633     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.11.107     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71
2. Cooperberg M.R., Broering J.M., Kantoff P.W., and Carroll P.R. Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178 (2007) S14
3. Cooperberg M.R., Moul J.W., and Carroll P.R. The changing face of prostate cancer. J Clin Oncol 23 (2005) 8146
4. Draisma G., Boer R., Otto S.J., van derCruijsen I.W., Damhuis R.A., Schroder F.H., et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95 (2003) 868
5. Bastian P.J., Mangold L.A., Epstein J.I., and Partin A.W. Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 101 (2004) 2001
6. Epstein J.I., Walsh P.C., Carmichael M., and Brendler C.B. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271 (1994) 368
7. Dall'Era M.A., Konety B.R., Cowan J.E., Shinohara K., Stauf F., Cooperberg M.R., et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112 (2008) 2664
8. Carter H.B., Kettermann A., Warlick C., Metter E.J., Landis P., Walsh P.C., et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urol 178 (2007) 2359
9. Hardie C., Parker C., Norman A., Eeles R., Horwich A., Huddart R., et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 95 (2005) 956
10. Loblaw DA, Choo R, Zhang L, Danjoux C, Morton GC, Holden L et al: Updated follow-up of active surveillance with selected delayed intervention for localized prostate cancer. Abstract 37, presented at ASCO Prostate Cancer Symposium, San Francisco, California, February 24-26, 2006.
11. Patel M.I., DeConcini D.T., Lopez-Corona E., Ohori M., Wheeler T., and Scardino P.T. An analysis of men with clinically localized prostate cancer who deferred definitive therapy. J Urol 171 (2004) 1520
12. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer, New York
13. San Francisco I.F., DeWolf W.C., Rosen S., Upton M., and Olumi A.F. Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy. J Urol 169 (2003) 136
14. Jeldres C., Suardi N., Walz J., Hutterer G.C., Ahyai S., Lattouf J.B., et al. Validation of the contemporary Epstein criteria for insignificant prostate cancer in European men. Eur Urol 54 (2008) 1306
15. Cam K., Yucel S., Turkeri L., and Akdas A. Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens. Int J Urol 9 (2002) 257
16. Bostwick D.G. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Pathol 18 (1994) 796
17. King C.R. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer 90 (2000) 305
18. Allsbrook Jr. W.C., Mangold K.A., Johnson M.H., Lane R.B., Lane C.G., Amin M.B., et al. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. Hum Pathol 32 (2001) 74
19. Thompson I.M., Canby-Hagino E., and Lucia M.S. Stage migration and grade inflation in prostate cancer: Will Rogers meets Garrison Keillor. J Natl Cancer Inst 97 (2005) 1236